Education Services

Ruanyun Edai Tech

Ruanyun Edai Tech released FY2025 Annual Earnings on July 31 (EST), actual revenue USD 6.685 M, actual EPS USD -0.0132

Ruanyun Edai Tech released FY2025 Q4 earnings on July 31 (EST), actual revenue USD 1.288 M, actual EPS USD 0.0036

Ruanyun Edai Tech released FY2025 9 Months earnings on July 31 (EST), actual revenue USD 5.398 M, actual EPS USD -0.0168

Ruanyun Edai Tech released FY2025 Q3 earnings on July 31 (EST), actual revenue USD 1.288 M, actual EPS USD 0.0036

Ruanyun Edai Tech released FY2024 9-month earnings on July 31 (EST), actual revenue USD 7.714 M, actual EPS USD -0.0583

Ruanyun Edai Tech released FY2024 Q4 earnings on July 31 (EST), actual revenue USD 1.44 M, actual EPS USD -0.0085

Ruanyun Edai Tech released FY2024 Q3 earnings on July 31 (EST), actual revenue USD 1.44 M, actual EPS USD -0.0085

Ruanyun Edai Technology Inc. released FY2025 Q1 earnings on January 8, 2025 (EST), with actual revenue of 2.055 M USD and EPS of -0.0102 USD

Ruanyun Edai Technology Inc. released FY2024 Q2 earnings on January 8, 2025 (EST), with actual revenue of 3.137 M USD and EPS of -0.0248 USD

Ruanyun Edai Technology Inc. released FY2025 Q2 earnings on January 8, 2025 (EST), with actual revenue of 2.055 M USD and EPS of -0.0102 USD

Ruanyun Edai Technology Inc. released FY2024 Q1 earnings on January 8, 2025 (EST), with actual revenue of 3.137 M USD and EPS of -0.0248 USD

Ruanyun Edai Technology Inc. released FY2025 Semi-Annual Earnings on January 8 (EST), with actual revenue of 4.11 M USD and EPS of -0.0205 USD

Ruanyun Edai Technology Inc. released FY2024 Semi-Annual Earnings on January 8, 2025 (EST), with actual revenue of 6.274 M USD and EPS of -0.0497 USD

Ruanyun Edai Technology Inc. released FY2024 annual earnings on August 30 (EST), with actual revenue of 9.154 M USD and EPS of -0.0668 USD

Ruanyun Edai Technology Inc. released FY2023 annual earnings on August 30 (EST), with actual revenue of 9.133 M USD and EPS of -0.0392 USD

Processa Pharmaceuticals

Agape ATP

cbdMD

VYNE Therapeutics

Inspirato

Mega Fortune

Globavend

Andersen

DBV Tech

Medline Inc.

Pearson

New Oriental EDU & Tech

Duolingo

TAL Edu

Bright Horizons Family Solutions

Laureate Edu

Graham-B

Grand Canyon Edu

Adtalem Global Edu

Stride

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap